We recently published a list of 10 Best Major Stocks to Invest In According to Analysts. In this article, we are going to ...

The company imports some of its active pharmaceutical ingredient, or semaglutide, into the U.S. for its blockbuster diabetes ...

In mid-September, Novo Nordisk inked a pair of deals worth a total of more than $1.1 billion in research and development (R&D ...

Novo Nordisk Gulf receives prestigious Best Places to Work Certification in Kuwait, Qatar, Bahrain, and Oman for 2024 ...

(Reuters) - Danish drugmaker Novo Nordisk has mitigation plans in place to minimize or prevent any disruption to its ...

"Pharmacy middlemen" are to blame for the high cost of drugs like Wegovy and Ozempic, according to Novo Nordisk's CEO. Is ...

AbbVie Humira, Pfizer/BioNTech COVID-19 shot may not make top 10 pharma drugs in 2024, with Novo Nordisk Ozempic and ...

Shares in telehealth group Hims & Hers Health (NYSE:HIMS) dropped in premarket US trading on Thursday after federal drug ...

Eli Lilly’s blockbuster obesity and diabetes drugs Zepbound and Mounjaro are no longer in shortage, according to the Food and ...

German drug and development company Evotec has entered into a technology development partnership with Novo Nordisk to support ...

(HealthDay News) — During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced tough questions over the company’s high prices for its blockbuster ...

Eli Lilly will invest $4.5 billion to create the Lilly Medicine Foundry, which the drug giant says will be the first-ever ...